PCS
ISEE

Personal CFO Solutions’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Personal CFO Solutions’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,800
Closed -$182K – 507
2022
Q1 		$182K Sell
10,800
-500
-4% -$7.39K 0.04% 442
2021
Q4 		$189K Hold
11,300
– – 0.04% 453
2021
Q3 		$184K Sell
11,300
-700
-6% -$7.62K 0.04% 424
2021
Q2 		$76K Hold
12,000
– – 0.02% 429
2021
Q1 		$74K Hold
12,000
– – 0.02% 398
2020
Q4 		$83K Hold
12,000
– – 0.02% 363
2020
Q3 		$0 Buy
12,000
+500
+4% +$2.38K ﹤0.01% 346
2020
Q2 		$59K Buy
+11,500
New +$47.9K 0.02% 302

Other funds holding ISEE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Personal CFO Solutions's ISEE Position: Q2 2022 in Review

Personal CFO Solutions sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2022, closing a stake of 10,800 shares — an estimated $182K sold.

Personal CFO Solutions first reported a position in ISEE in Q2 2020 and held it in 8 quarters. The position peaked at $189K in Q4 2021. 184 funds tracked by Wall St. Rank hold ISEE as of Q2 2022.

  • Personal CFO Solutions reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Personal CFO Solutions sold 10,800 IVERIC bio, Inc. Common Stock shares in Q2 2022, an estimated $182K.
  • Personal CFO Solutions first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Personal CFO Solutions's IVERIC bio, Inc. Common Stock position peaked at $189K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2022.

Based on Personal CFO Solutions's 13F filing for Q2 2022, filed 5 Aug 2022.